Arkolith/Insider Trading/TENX/Form 4/A

Almenoff June Sherie

DirectorTENAX THERAPEUTICS, INC. (TENX) · full profile →Form 4/A · filed Nov 20, 2025
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2025Buy(P)2K$7.52$14K2K
Nov 17, 2025Buy(P)93$7.15$66593

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001492647-25-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML